Delphi Diagnostics

2 known investors

Delphi Diagnostics develops genomic diagnostic tests to personalize breast cancer treatment for healthcare providers. The company's Endocrine Activity Index measures endocrine transcriptional activity in early-stage hormone receptor-positive breast cancer to help optimize chemotherapy decisions and improve patient outcomes.

BiotechDigital HealthMedical Devices